Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofra Maimon

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Anticancer Research|July 26, 2024
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case ReportOfra Maimon, Benjamin Nisman, Shani Broier, et al.
Frontiers in Oncology|September 20, 2021
"High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis"Shay Shraga, Albert Grinshpun, Aviad Zick, et al.
Journal of Clinical Medicine|November 27, 2025
Outcomes of Lobar and Sublobar Resection for Clinical Stage I Lung Neuroendocrine Tumors: An ENETS Center of Excellence ExperienceRanin Hojerat, Islam Idais, Gal Aviel, et al.
Frontiers in Cell and Developmental Biology|November 13, 2023
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cellsAvital Granit Mizrahi, Ahinoam Gugenheim, Haneen Hamad, et al.
Endocrine|February 10, 2020
Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experienceKira Oleinikov, Inbal Uri, Harold Jacob, et al.
Scientific Reports|February 29, 2020
Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified GenesMyriam Maoz, Michal Devir, Michal Inbar, et al.
Scientific Reports|December 13, 2019
Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified GenesMyriam Maoz, Michal Devir, Michal Inbar, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2024
Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implicationsEster Davis, Shani Avniel-Polak, Shahd Abu-Kamel, et al.
NPJ Breast Cancer|June 2, 2023
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort studyOfer Rotem, Idit Peretz, Michelle Leviov, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Anticancer Research|July 26, 2024
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case ReportOfra Maimon, Benjamin Nisman, Shani Broier, et al.
Frontiers in Oncology|September 20, 2021
"High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis"Shay Shraga, Albert Grinshpun, Aviad Zick, et al.
Journal of Clinical Medicine|November 27, 2025
Outcomes of Lobar and Sublobar Resection for Clinical Stage I Lung Neuroendocrine Tumors: An ENETS Center of Excellence ExperienceRanin Hojerat, Islam Idais, Gal Aviel, et al.
Frontiers in Cell and Developmental Biology|November 13, 2023
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cellsAvital Granit Mizrahi, Ahinoam Gugenheim, Haneen Hamad, et al.
Endocrine|February 10, 2020
Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experienceKira Oleinikov, Inbal Uri, Harold Jacob, et al.
Scientific Reports|February 29, 2020
Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified GenesMyriam Maoz, Michal Devir, Michal Inbar, et al.
Scientific Reports|December 13, 2019
Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified GenesMyriam Maoz, Michal Devir, Michal Inbar, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2024
Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implicationsEster Davis, Shani Avniel-Polak, Shahd Abu-Kamel, et al.
NPJ Breast Cancer|June 2, 2023
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort studyOfer Rotem, Idit Peretz, Michelle Leviov, et al.
Pageof 3